Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACell
Columbia, Maryland, USAacell.com ↗
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
01
Overview
ACell's UBM-based products (MatriStem, Cytal, MicroMatrix, Gentrix) are supported by 200+ preclinical and clinical publications, cleared by FDA for several indications in wound care and surgical repair; now part of Integra LifeSciences post-acquisition
- Therapeutic areas
- Women's HealthGastroenterologyOtherDermatology
- Modalities
- BiologicExtracellular matrix scaffold (ECM-derived biologics)
- Industry
- Surgical Medical Devices
02
Partnerships
Integration and partnership through acquisition by Integra LifeSciences
Beyond the preview
Go deeper on ACell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACell.